1) renal transitional cell carcinomas
肾移行细胞癌
2) transitional cell carcinoma of renal pelvis
肾盂移行细胞癌
1.
Expression of epithelial membrane antigen in renal cell carcinoma and transitional cell carcinoma of renal pelvis;
上皮细胞膜抗原在肾细胞癌和肾盂移行细胞癌中的表达
3) renal pelvic transitional cell carcinoma
肾盂移行细胞癌
1.
Objective To study the expression of thrombomodulin (TM) in renal pelvic transitional cell carcinoma and in renal cell carcinoma.
目的研究血栓调节蛋白(TM)在肾盂移行细胞癌及肾细胞癌中的表达及临床意义。
4) Transitional cell carcinoma
移行细胞癌
1.
Expression of octamer binding factor 4 in human transitional cell carcinoma tissue of bladder;
人膀胱移行细胞癌组织中八聚体转录因子4蛋白表达
2.
Relationship of survivin expression and level of AKT_1,caspase3 protein and mRNA in bladder transitional cell carcinomas;
膀胱移行细胞癌Survivin表达与AKT_1和Caspase3蛋白活性及转录水平的关系
3.
Expression of erythropoietin and its receptor in transitional cell carcinoma of bladder;
膀胱移行细胞癌中促红细胞生成素及其受体的表达
5) TCC
移行细胞癌
1.
Express and Significance of PPAR-γ、EGR-1 in Transitional Cell Carcinoma (TCC) of Bladder;
PPAR-γ、EGR-1在膀胱移行细胞癌中的表达及其意义
2.
Expression of Vascular Endothelial Growth Factor C(VEGF-C) and Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) in Transitional Cell Carcinoma (TCC) of Bladder;
血管内皮生长因子C及其受体在膀胱移行细胞癌中的表达
3.
Objective To study the expression pattern and role of VEGF-C and VEGFR-3 in TCC of Urinary bladder.
目的探讨血管内皮生长因子C(VEGF-C)及其受体(VEGFR-3)在膀胱移行细胞癌组织中的表达及其意义。
6) mRCC
转移性肾细胞癌
1.
Although there is currently no curative therapeutic modalities for metastatic renal cell carcinoma(mRCC), several investigational strategies have shown initial encouraging results.
转移性肾细胞癌 (mRCC)目前尚无治愈性措施。
补充资料：肾细胞癌
肾细胞癌
又称"肾腺癌"，简称"肾癌"。是泌尿系最常见的肿瘤，约占肾脏肿瘤的75％，男性多于女性，多见于50～60岁的老年人。肾细胞癌由肾小管上皮细胞发生，肿瘤一般为单个，圆形，切面呈黄色。临床上，早期肿瘤体积小，可无特殊症状，后期典型者为血尿、腰痛与腰部肿块三联症，但多数不全部同时出现，常以血尿为首，多为无痛性全程血尿，呈间歇性，此外可有发热，乏力，消瘦等全身症状。肾癌常可通过血管和淋巴管转移。除根治性肾切除外，其他疗效差、预后坏。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条